Liquid Biopsy Market 2018 : Demonstrates Enormous Growth by 2022; Predicts the MRFR
The Global Liquid Biopsy Market is currently valued at $ 3950 million and will reach $ 17,372.28 million growing at a CAGR of 28%. The growth factors responsible for this explosive growth are liquid biopsy is a comparatively painless and non-invasive technique which provides early real time high precision detection of diseases which could be used for monitoring and designing effective treatment strategies based on the real time molecular assessment for the progression of the disease. Other factors driving the...
View full press release